FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37406311000001105: NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
308271000001117 NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
308281000001115 NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Is a Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Is a NuvaRing true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has specific active ingredient Etonogestrel true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has dispensed dose form Vaginal delivery system true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) 3 system Has AMP True NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start